chr5-140488-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_052909.5(PLEKHG4B):c.1249G>A(p.Glu417Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000658 in 1,595,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052909.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLEKHG4B | NM_052909.5 | c.1249G>A | p.Glu417Lys | missense_variant | 3/20 | ENST00000637938.2 | NP_443141.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLEKHG4B | ENST00000637938.2 | c.1249G>A | p.Glu417Lys | missense_variant | 3/20 | 5 | NM_052909.5 | ENSP00000490806.1 | ||
PLEKHG4B | ENST00000283426.11 | c.181G>A | p.Glu61Lys | missense_variant | 1/18 | 1 | ENSP00000283426.6 |
Frequencies
GnomAD3 genomes AF: 0.000290 AC: 44AN: 151934Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000926 AC: 20AN: 215942Hom.: 0 AF XY: 0.0000513 AC XY: 6AN XY: 116986
GnomAD4 exome AF: 0.0000423 AC: 61AN: 1443650Hom.: 0 Cov.: 34 AF XY: 0.0000419 AC XY: 30AN XY: 716450
GnomAD4 genome AF: 0.000289 AC: 44AN: 152052Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2022 | The c.181G>A (p.E61K) alteration is located in exon 1 (coding exon 1) of the PLEKHG4B gene. This alteration results from a G to A substitution at nucleotide position 181, causing the glutamic acid (E) at amino acid position 61 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at